Vaccine Strategies to Elicit Mucosal Immunity
- PMID: 38400174
- PMCID: PMC10892965
- DOI: 10.3390/vaccines12020191
Vaccine Strategies to Elicit Mucosal Immunity
Abstract
Vaccines are essential tools to prevent infection and control transmission of infectious diseases that threaten public health. Most infectious agents enter their hosts across mucosal surfaces, which make up key first lines of host defense against pathogens. Mucosal immune responses play critical roles in host immune defense to provide durable and better recall responses. Substantial attention has been focused on developing effective mucosal vaccines to elicit robust localized and systemic immune responses by administration via mucosal routes. Mucosal vaccines that elicit effective immune responses yield protection superior to parenterally delivered vaccines. Beyond their valuable immunogenicity, mucosal vaccines can be less expensive and easier to administer without a need for injection materials and more highly trained personnel. However, developing effective mucosal vaccines faces many challenges, and much effort has been directed at their development. In this article, we review the history of mucosal vaccine development and present an overview of mucosal compartment biology and the roles that mucosal immunity plays in defending against infection, knowledge that has helped inform mucosal vaccine development. We explore new progress in mucosal vaccine design and optimization and novel approaches created to improve the efficacy and safety of mucosal vaccines.
Keywords: mucosal adjuvant; mucosal barrier; mucosal immunity; mucosal vaccine; vaccine delivery; vaccine development.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Mucosal immunization: a review of strategies and challenges.Crit Rev Ther Drug Carrier Syst. 2014;31(4):273-303. doi: 10.1615/critrevtherdrugcarriersyst.2014010102. Crit Rev Ther Drug Carrier Syst. 2014. PMID: 25072196 Review.
-
Vaccines, adjuvants and key factors for mucosal immune response.Immunology. 2022 Oct;167(2):124-138. doi: 10.1111/imm.13526. Epub 2022 Jul 12. Immunology. 2022. PMID: 35751397 Review.
-
Harnessing the potential of the NALT and BALT as targets for immunomodulation using engineering strategies to enhance mucosal uptake.Front Immunol. 2024 Sep 2;15:1419527. doi: 10.3389/fimmu.2024.1419527. eCollection 2024. Front Immunol. 2024. PMID: 39286244 Free PMC article. Review.
-
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience.EBioMedicine. 2023 Jun;92:104585. doi: 10.1016/j.ebiom.2023.104585. Epub 2023 May 3. EBioMedicine. 2023. PMID: 37146404 Free PMC article. Review.
-
Mucosal vaccine design and delivery.Annu Rev Biomed Eng. 2012;14:17-46. doi: 10.1146/annurev-bioeng-071811-150054. Epub 2012 Apr 18. Annu Rev Biomed Eng. 2012. PMID: 22524387 Review.
Cited by
-
Safety, Immunogenicity and Protective Activity of a Modified Trivalent Live Attenuated Influenza Vaccine for Combined Protection Against Seasonal Influenza and COVID-19 in Golden Syrian Hamsters.Vaccines (Basel). 2024 Nov 21;12(12):1300. doi: 10.3390/vaccines12121300. Vaccines (Basel). 2024. PMID: 39771962 Free PMC article.
-
Double-layered protein nanoparticles conjugated with truncated flagellin induce improved mucosal and systemic immune responses in mice.Nanoscale Horiz. 2024 Oct 21;9(11):2016-2030. doi: 10.1039/d4nh00287c. Nanoscale Horiz. 2024. PMID: 39240547 Free PMC article.
-
Advancing veterinary vaccines design through trained immunity insights.Front Vet Sci. 2025 Jan 15;11:1524668. doi: 10.3389/fvets.2024.1524668. eCollection 2024. Front Vet Sci. 2025. PMID: 39881716 Free PMC article.
-
Chlamydia muridarum mutant CM-pGP3S as a novel attenuated live rectal vaccine protects against genital tract infection.Front Cell Infect Microbiol. 2025 May 13;15:1550455. doi: 10.3389/fcimb.2025.1550455. eCollection 2025. Front Cell Infect Microbiol. 2025. PMID: 40433661 Free PMC article.
-
New insights for the development of efficient DNA vaccines.Microb Biotechnol. 2024 Nov;17(11):e70053. doi: 10.1111/1751-7915.70053. Microb Biotechnol. 2024. PMID: 39545748 Free PMC article. Review.
References
-
- Leung A.K.C. “Variolation” and Vaccination in Late Imperial China, Ca 1570–1911. In: Plotkin S.A., editor. History of Vaccine Development. Springer; New York, NY, USA: 2011. pp. 5–12.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources